Here are three points:
1. VertiFlex proposes to raise a total of $45.7 million in funding.
2. The company’s Superion Interspinous Spacer device received pre-market approval from the FDA last year to treat moderate lumber spinal stenosis.
3. VertiFlex has raised $93 million in funding rounds since 2007.
More articles on devices:
Amedica adds 2nd generational cervical system—5 highlights
SeaSpine, K2M, Smith & Nephew & more: 16 key notes
Is the Johnson & Johnson job cut an ominous sight for the medical device industry? 5 key thoughts
